​

Cogent Biosciences Ownership | Who Owns Cogent Biosciences?

OverviewForecastRevenueFinancialsChart

Cogent Biosciences Ownership Summary

Cogent Biosciences is owned by 117.80% institutional investors, 0.16% insiders. Fmr is the largest institutional shareholder, holding 15.04% of COGT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.71% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCogent Biosciences117.80%0.16%-17.96%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.57M15.04%$129.24M
Kynam capital management, lp9.11M8.26%$71.02M
Blackrock funding, inc. /de8.34M7.57%$65.05M
Blackrock7.29M7.34%$61.44M
Tcg crossover management6.96M6.32%$54.32M
Commodore capital lp6.88M6.25%$53.68M
Fairmount funds management6.23M5.65%$48.56M
Vanguard group6.13M5.57%$47.84M
Vr adviser5.68M5.16%$44.34M
Point72 asset management5.35M4.85%$41.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp910.87K6.15%$7.10M
Tcg crossover management6.96M5.31%$54.32M
Fairmount funds management6.23M4.83%$48.56M
Saturn v capital management1.50M4.58%$11.69M
Kynam capital management, lp9.11M4.20%$71.02M
Commodore capital lp6.88M3.93%$53.68M
Octagon capital advisors lp2.76M3.55%$21.55M
Vr adviser5.68M3.04%$44.34M
New leaf venture partners250.76K2.61%$1.96M
Redmile group3.55M1.93%$27.73M

Top Buyers

HolderShares% AssetsChange
Fmr16.57M0.01%8.25M
Octagon capital advisors lp2.76M3.55%1.46M
Superstring capital management lp910.87K6.15%910.87K
State street3.92M0.00%686.67K
Blackrock7.29M0.00%598.76K

Top Sellers

HolderShares% AssetsChange
Point72 asset management5.35M0.09%-5.12M
Adage capital partners gp---4.30M
Logos global management lp---2.00M
Millennium management56.51K0.00%-1.56M
Sofinnova investments823.16K0.47%-1.44M

New Positions

HolderShares% AssetsChangeValue
Superstring capital management lp910.87K6.15%910.87K$7.10M
Renaissance242.93K0.00%242.93K$1.89M
Bnp paribas arbitrage, snc66.78K0.00%66.78K$520.91K
Xtx topco58.56K0.04%58.56K$456.77K
Entrypoint capital52.35K0.17%52.35K$408.30K

Sold Out

HolderChange
Clear point advisors-1.00
National bank of canada /fi/-1.00
Ifp advisors-8.00
Nelson, van denburg & campbell wealth management group-16.00
Srs capital advisors-28.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251841.10%133,476,5659.67%1170.97%98-482.13%
Dec 31, 20241799.15%120,758,047-0.89%1090.90%9612.94%484.35%
Sep 30, 20241616.62%121,811,5570.36%1100.74%846.33%46-4.17%
Jun 30, 2024151-3.21%121,368,54811.09%1220.92%79-20.20%4837.14%
Mar 31, 20241564.70%109,251,85420.30%1151.05%992.06%3516.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.09M2.71%-
Vanguard Total Stock Mkt Idx Inv3.47M2.49%-
Fidelity Select Health Care3.14M2.25%875.82K
Fidelity Small Cap Growth2.57M1.85%-6.28K
iShares Russell 2000 ETF2.56M1.84%-41.41K
FIAM Small Cap Core Composite1.87M1.69%225.12K
Fidelity Advisor Biotechnology I2.00M1.43%665.41K
FIAM Small Cap Core CIT Cl B1.83M1.31%-15.60K
Fidelity Advisor Health Care I1.80M1.29%429.44K
Vanguard Institutional Extnd Mkt Idx Tr1.66M1.19%7.37K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 10, 2025Fairmount Funds Management LLC-Buy$25.00M
Jan 14, 2025Pinnow Cole Chief Commercial OfficerBuy$332.41K
Jun 09, 2023Fairmount Funds Management LLC-Buy$9.60M
Jun 16, 2022Fairmount Funds Management LLC Buy$9.90M
Apr 26, 2021Green John L. Chief Financial OfficerSell$157.82K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q11-
2024 Q4--
2024 Q3--

COGT Ownership FAQ

Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 117.80%, followed by 0.16% insiders and -17.96% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 64.05%, which Cogent Biosciences exceeds.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Fmr (16.57M shares, 15.04%), Kynam capital management, lp (9.1M shares, 8.26%), and Blackrock funding, inc. /de (8.34M shares, 7.57%). Together, they hold 30.87% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 6.15% of its assets in 910.86K Cogent Biosciences shares, valued at 7.1M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cogent Biosciences shares, with 2.71% of its total shares outstanding invested in 3.09M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools